Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 2 |
2024 | 5 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
borden bl[au]
(8 results)?
Ultrasensitive detection of circulating LINE-1 ORF1p as a specific multi-cancer biomarker.
bioRxiv [Preprint]. 2023 Mar 17:2023.01.25.525462. doi: 10.1101/2023.01.25.525462.
bioRxiv. 2023.
PMID: 36747644
Free PMC article.
Updated.
Preprint.
Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker.
Taylor MS, Wu C, Fridy PC, Zhang SJ, Senussi Y, Wolters JC, Cajuso T, Cheng WC, Heaps JD, Miller BD, Mori K, Cohen L, Jiang H, Molloy KR, Chait BT, Goggins MG, Bhan I, Franses JW, Yang X, Taplin ME, Wang X, Christiani DC, Johnson BE, Meyerson M, Uppaluri R, Egloff AM, Denault EN, Spring LM, Wang TL, Shih IM, Fairman JE, Jung E, Arora KS, Yilmaz OH, Cohen S, Sharova T, Chi G, Norden BL, Song Y, Nieman LT, Pappas L, Parikh AR, Strickland MR, Corcoran RB, Mustelin T, Eng G, Yilmaz ÖH, Matulonis UA, Chan AT, Skates SJ, Rueda BR, Drapkin R, Klempner SJ, Deshpande V, Ting DT, Rout MP, LaCava J, Walt DR, Burns KH.
Taylor MS, et al. Among authors: norden bl.
Cancer Discov. 2023 Dec 12;13(12):2532-2547. doi: 10.1158/2159-8290.CD-23-0313.
Cancer Discov. 2023.
PMID: 37698949
Free PMC article.
Item in Clipboard
Allosteric PI3Kα Inhibition Overcomes On-target Resistance to Orthosteric Inhibitors Mediated by Secondary PIK3CA Mutations.
Varkaris A, Fece de la Cruz F, Martin EE, Norden BL, Chevalier N, Kehlmann AM, Leshchiner I, Barnes H, Ehnstrom S, Stavridi AM, Yuan X, Kim JS, Ellis H, Papatheodoridi A, Gunaydin H, Danysh BP, Parida L, Sanidas I, Ji Y, Lau K, Wulf GM, Bardia A, Spring LM, Isakoff SJ, Lennerz JK, Del Vecchio K, Pierce L, Pazolli E, Getz G, Corcoran RB, Juric D.
Varkaris A, et al. Among authors: norden bl.
Cancer Discov. 2024 Feb 8;14(2):227-239. doi: 10.1158/2159-8290.CD-23-0704.
Cancer Discov. 2024.
PMID: 37916958
Free PMC article.
Item in Clipboard
Landscape of Clinical Resistance Mechanisms to FGFR Inhibitors in FGFR2-Altered Cholangiocarcinoma.
Wu Q, Ellis H, Siravegna G, Michel AG, Norden BL, Fece de la Cruz F, Balasooriya ER, Zhen Y, Silveira VS, Che J, Corcoran RB, Bardeesy N.
Wu Q, et al. Among authors: norden bl.
Clin Cancer Res. 2024 Jan 5;30(1):198-208. doi: 10.1158/1078-0432.CCR-23-1317.
Clin Cancer Res. 2024.
PMID: 37843855
Free PMC article.
Item in Clipboard
Sotorasib is a pan-RASG12C inhibitor capable of driving clinical response in NRASG12C cancers.
Rubinson DA, Tanaka N, Fece de la Cruz F, Kapner KS, Rosenthal MH, Norden BL, Barnes H, Ehnstrom S, Morales-Giron AA, Brais LK, Lemke CT, Aguirre AJ, Corcoran RB.
Rubinson DA, et al. Among authors: norden bl.
Cancer Discov. 2024 Jan 18. doi: 10.1158/2159-8290.CD-23-1138. Online ahead of print.
Cancer Discov. 2024.
PMID: 38236605
Item in Clipboard
The irreversible FGFR inhibitor KIN-3248 overcomes FGFR2 kinase domain mutations.
Balasooriya ER, Wu Q, Ellis H, Zhen Y, Norden BL, Corcoran RB, Mohan A, Martin E, Franovic A, Tyhonas J, Lardy M, Grandinetti KB, Pelham R, Soroceanu L, Silveira VS, Bardeesy N.
Balasooriya ER, et al. Among authors: norden bl.
Clin Cancer Res. 2024 Mar 4. doi: 10.1158/1078-0432.CCR-23-3588. Online ahead of print.
Clin Cancer Res. 2024.
PMID: 38437671
Item in Clipboard
Phase 1/2 study of combined BCL-xL and MEK inhibition with navitoclax and trametinib in KRAS or NRAS mutant advanced solid tumors.
Corcoran RB, Do KT, Kim JE, Cleary JM, Parikh AR, Yeku OO, Xiong N, Weekes CD, Veneris J, Ahronian LG, Mauri G, Tian J, Norden BL, Michel AG, Van Seventer EE, Siravegna G, Camphausen K, Chi G, Fetter IJ, Brugge JS, Chen HX, Takebe N, Penson RT, Juric D, Flaherty KT, Sullivan RJ, Clark JW, Heist RS, Matulonis UA, Liu JF, Shapiro GI.
Corcoran RB, et al. Among authors: norden bl.
Clin Cancer Res. 2024 Mar 8. doi: 10.1158/1078-0432.CCR-23-3135. Online ahead of print.
Clin Cancer Res. 2024.
PMID: 38456660
Item in Clipboard
Cite
Cite